Skip to content

Impact of QoLibri Medical Device on the Consequences of Chronic Pain: a Randomized Controlled Trial

RecruitingNot applicableNCT06841276
View the official record on ClinicalTrials.gov

Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.

This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.

Brief summary (from the registry)

A superiority study evaluating the impact of the QoLibri Software as Medical Device on functional and psychological consequences of chronic pain in primary care patients. A prospective, cluster-randomized, wait list, controlled multicentre study with the main objective of evaluating the effectiveness of the QoLibri Digital Therapy on Quality of Life improvement in patients living with chronic pain.

Study details

Official title
Evaluation of the Impact of the QoLibri Digital Therapy on Primary Care Patients With Chronic Pain: a Randomized Controlled Clinical Trial.
Conditions
Interventions
  • Device: QoLibri Digital Therapy
Sponsor
Novesia
Start date
2025-02-28
Primary completion
2027-03
Sex
All
Age range
from 18 Years
Results posted
No results posted in this snapshot
Countries
France
Total sites listed
1

Eligibility criteria

Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Patient experiencing at least moderate pain (on the Categorical Pain Scale) for more than 3 months * Patient with a BPI interference score ≥ 3 in at least 3 out of 7 dimensions * Patient with a smartphone and an internet connection at the place of use * Patient affiliated with a social security system or benefiting from such a system Exclusion Criteria: * Patient opposing participation in the study * Patient with severe anxiety and/or depressive disorders (especially a suicidal risk) * Patient presenting one or more barriers to the initiation of cognitive-behavioral therapy (significant social difficulties, low adherence to current care, insufficient memory or cognitive abilities, lack of time, lack of motivation...), * Adult patient under legal protection measures (guardianship, legal safeguard, psychiatric care, or deprived of liberty by judicial or administrative decision)

Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT06841276